πŸ‡ΊπŸ‡Έ FDA
Patent

US 7199223

Polymer-factor VIII moiety conjugates

granted A61KA61K38/37A61K47/10

Quick answer

US patent 7199223 (Polymer-factor VIII moiety conjugates) held by Nektar Therapeutics AL, Corporation expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics AL, Corporation
Grant date
Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/37, A61K47/10, A61K47/60, A61P